Laparoscopic Vertical Sleeve Gastrectomy as a Treatment Option for Adults with Diabetes Mellitus

Koch, Timothy R.; Shope, Timothy

doi:10.1007/5584_2020_487

Cited by 5 publications

(4 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In accordance with the observed increase of research regarding morbidity and surgical complications in general[ 47 - 53 ], our results demonstrated a continued increase of sleeve gastrectomy literature since 2001. This progress was particularly prominent since 2010, which coincided with the shift in focusing on developing tools for surgical techniques[ 54 - 57 ] and the correlation of sleeve gastrectomy with diabetes mellitus and body mass index[ 58 - 67 ].…”

Section: Discussionmentioning

confidence: 99%

Global trends in research related to sleeve gastrectomy: A bibliometric and visualized study

Barqawi¹,

Abushamma²,

Akkawi³

et al. 2021

WJGS

View full text Add to dashboard Cite

BACKGROUND One of the most popular bariatric procedures is sleeve gastrectomy, and it has become significantly more common in recent years. AIM To evaluate the research activity in sleeve gastrectomy over the last two decades, and to visualize the hot spots and emerging trends in this type of bariatric surgery using bibliometric methods. METHODS The Scopus database was used to search for publications related to sleeve gastrectomy. The retrieved publications were reviewed in terms of year of publication, type of study, country of origin, institutions, journals, and citation patterns by using descriptive analysis. Collaboration network and term co-occurrence analysis were visualized by using VOSviewer software. RESULTS The search strategy yielded a total of 6508 publications on sleeve gastrectomy from 2001 to 2020. As regards the document type, the majority were articles ( n = 5230; 80.36%), followed by reviews ( n = 544; 8.36%). The top three countries are the United States, with 1983 publications (30.47%), followed by France (600; 9.22%) and Italy (417; 6.71%). The most cited publication was published in 2012 by Schauer et al in the New England Journal of Medicine ( n = 1435 citations). This publication found that weight loss was greater in the sleeve gastrectomy group than in the medical therapy group. Furthermore, this study demonstrated that 12 mo of medical therapy plus bariatric surgery greatly improved glycemic regulation in obese patients with uncontrolled type 2 diabetes compared with medical therapy alone. The focus of the current literature on sleeve gastrectomy was directed toward several themes such as morbidity and potential complications, the complexity of the procedure and different surgical approaches, and diabetes and body mass index in correlation to sleeve gastrectomy. CONCLUSION The number of sleeve gastrectomy publications has gradually grown over the last 20 years. This bibliometric analysis could help researchers better understand the knowledge base and research frontiers surrounding sleeve gastrectomy. In addition, future studies may focus on emerging research hotspots.

show abstract

Section: Discussionmentioning

confidence: 99%

Global trends in research related to sleeve gastrectomy: A bibliometric and visualized study

Barqawi¹,

Abushamma²,

Akkawi³

et al. 2021

WJGS

View full text Add to dashboard Cite

show abstract

“…The prevalence of T2DM is greater than 25% in older patients over 65 years of age; treatment of older patients is more difficult because complications are more likely to occur ( 6 , 7 ). Today, the main treatment strategies for T2DM include surgery, pharmacotherapy, exercise therapy, diet, nutrition and multifactorial therapy ( 8 , 9 ). The core of the treatment of T2DM is to solve the problem of hyperglycemia.…”

Section: Introductionmentioning

confidence: 99%

Gut microbiota: A new target for T2DM prevention and treatment

et al. 2022

View full text Add to dashboard Cite

Type 2 diabetes mellitus (T2DM), one of the fastest growing metabolic diseases, has been characterized by metabolic disorders including hyperglycemia, hyperlipidemia and insulin resistance (IR). In recent years, T2DM has become the fastest growing metabolic disease in the world. Studies have indicated that patients with T2DM are often associated with intestinal flora disorders and dysfunction involving multiple organs. Metabolites of the intestinal flora, such as bile acids (BAs), short-chain fatty acids (SCFAs) and amino acids (AAs)may influence to some extent the decreased insulin sensitivity associated with T2DM dysfunction and regulate metabolic as well as immune homeostasis. In this paper, we review the changes in the gut flora in T2DM and the mechanisms by which the gut microbiota modulates metabolites affecting T2DM, which may provide a basis for the early identification of T2DM-susceptible individuals and guide targeted interventions. Finally, we also highlight gut microecological therapeutic strategies focused on shaping the gut flora to inform the improvement of T2DM progression.

show abstract

“…Type 2 diabetes mellitus (T2DM) is a typical metabolic disease characterised by impaired islet sensitivity and relatively insufficient insulin secretion ( Zhao et al, 2020 ). At present, the main treatment strategies for T2DM include surgery, medication, and diet ( Koch and Shope, 2020 ). Insulin injections are the most effective method for controlling blood sugar ( Home et al, 2014 ).…”

Section: Introductionmentioning

confidence: 99%